Determination of ofloxacin in human aqueous humour by high-performance liquid chromatography with fluorescence detection

A reversed-phase high-performance liquid chromatographic method is described for the determination of ofloxacin in human aqueous humour; the method involves fluroescence detection (excitation at 290 nm; emission at 500 nm) after direct injection of samples. The method utilized a 100 mm × 8 mm i.d. c...

Full description

Saved in:
Bibliographic Details
Published inJournal of pharmaceutical and biomedical analysis Vol. 15; no. 5; pp. 663 - 666
Main Authors Basci, N.E., Hanioglu-Kargi, S., Soysal, H., Bozkurt, A., Kayaalp, S.O.
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 01.02.1997
Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A reversed-phase high-performance liquid chromatographic method is described for the determination of ofloxacin in human aqueous humour; the method involves fluroescence detection (excitation at 290 nm; emission at 500 nm) after direct injection of samples. The method utilized a 100 mm × 8 mm i.d. cartridge column packed with 4 μm Novapak C 18 with a mobile phase methanol-acetonitrile-0.4 M citric acid (3:1:10, v/v/v) and a flow rate of 1 ml min −1 at ambient temperature. The retention times for the internal standard pipemidic acid and for ofloxacin were 4.82 and 7.32 min respectively. The mean recovery (± ISD) from human aqueous humour was 103.24 ± 4.45% for ofloxacin at 1 μg ml −1 ( n = 6). The within-day and day-to-day RSDs at 0.1 μg ml −1 and 1 μg ml −1 were less than 6.71% ( n = 6) and the lower limit of reliable determination corresponding to a signal-to-noise ratio of 2.5:1 was 20 ng ml −1. The assay was shown to be suitable for measuring ofloxacin levels in human aqueous humour samples after topical, oral and intravenous administration.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0731-7085
1873-264X
DOI:10.1016/S0731-7085(96)01889-4